Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: finding a needle in a haystack

Udayakumar Navaneethan

doi:10.1055/s-0042-103420

Endoscopy, Table of Contents

Endoscopy 2016; 48(05): 417-418
DOI: 10.1055/s-0042-103420

Editorial

Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: finding a needle in a haystack

Udayakumar Navaneethan

Center for Interventional Endoscopy, Florida Hospital, University of Central Florida College of Medicine, Orlando, Florida, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008; 48: 308-321
2 Chapman R, Fevery J, Kalloo A et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51: 660-678
3 de Valle MB, Bjornsson E, Lindkvist B. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int 2012; 32: 441-448
4 Charatcharoenwitthaya P, Enders FB, Halling KC et al. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106-1117
5 Rosen CB, Heimbach JK, Gores GJ. Liver transplantation for cholangiocarcinoma. Transpl Int 2010; 23: 692-697
6 Trikudanathan G, Navaneethan U, Njei B et al. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2014; 79: 783-789
7 Boyd S, Tenca A, Jokelainen K et al. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Endoscopy 2016; 48: 432-439
8 Navaneethan U, Njei B, Venkatesh PG et al. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2014; 79: 943-950
9 Navaneethan U, Jegadeesan R, Nayak S et al. ERCP-related adverse events in patients with primary sclerosing cholangitis. Gastrointest Endosc 2015; 81: 410-419
10 Meining A, Frimberger E, Becker V et al. Detection of cholangiocarcinoma in vivo using miniprobe-based confocal fluorescence microscopy. Clin Gastroenterol Hepatol 2008; 6: 1057-1060
11 Azeem N, Gostout CJ, Knipschield M et al. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc 2014; 79: 773-779
12 Navaneethan U, Hasan MK, Njei B et al. Digital single operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders. A multi-center clinical experience. Gastrointest Endosc 2016; In press
13 Navaneethan U, Parsi MA, Lourdusamy V et al. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study. Gastrointest Endosc 2015; 81: 943-949
14 Navaneethan U, Gutierrez NG, Venkatesh PG et al. Lipidomic profiling of bile in distinguishing benign from malignant biliary strictures: a single-blinded pilot study. Am J Gastroenterol 2014; 109: 895-902
15 Lankisch TO, Metzger J, Negm AA et al. Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 2011; 53: 875-884